A phase III, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia (VAYHIT1)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
Gemlyn George
Study ID
Protocol Number: 23-2506
More information available at ClinicalTrials.gov: NCT05653349
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers